Senior Medical Science Liaison jobs in United States
cer-icon
Apply on Employer Site
company-logo

CareDx, Inc. · 1 day ago

Senior Medical Science Liaison

CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of healthcare solutions for transplant patients. The Senior Medical Science Liaison will educate physicians and transplant coordinators about the clinical value of the AlloSure test and support product adoption through strong relationships with key opinion leaders and clinical support at transplant centers.

BiotechnologyHealth CareHealth DiagnosticsInformation Technology
badNo H1Bnote

Responsibilities

Communicate and reinforce the clinical utility of the AlloSure test
Develop strong and productive working relationships with key opinion leaders (KOLs) in the field of transplantation
Help analyze, interpret, and clarify the AlloSure test results in conjunction with other clinical data
Provide on-site clinical support at transplant centers through oral presentations, test result data reviews and interactive resolution of clinician queries
Function as the primary clinical resource for the Transplant Account Manager (TAM) team to support product adoption and expanded use of CareDx products
Assist new product development teams in defining unmet needs, product performance requirements, and launch plans
Provide clinical support for Customer Service inquiries and complaints
Participate in Medical Advisory Board meetings with KOLs
Participate in Clinical Workshop meetings with KOLs
Support company initiatives at clinical and scientific meetings
Function as a clinical liaison and resource to payer and insurance groups
Support Clinical Operations as needs with field support at transplant centers participating in CareDx sponsored trials

Qualification

Organ transplantation knowledgeMSL experienceOral presentation skillsPublication portfolioMolecular biology knowledgeInterpersonal skillsCollaborative work style

Required

Candidates must be located in either the Bay Area or Greater Los Angeles
Health care professionals with relevant clinical sciences knowledge in (kidney preferred) organ transplantation will be considered: PharmD, PhD, or MD
Minimum of 5+ yrs of related experience; Prior experience in MSL role highly preferred and/or the introduction of new clinical laboratory tests preferred
Outstanding oral presentation skills with a portfolio to support
Publication Portfolio
Ability to explain how AlloSure scores can be used and added to the milieu of other available clinical data, interpret clinical scenarios, and communicate diagnostic and management issues in transplant recipients
Experience in establishing strong, collaborative working relationships with clinicians
Experience in establishing strong, collaborative working relationships with internal stakeholder functions (e.g. Sales, Marketing, Regulatory, R&D) and external customers
Knowledge of molecular biology and immunology helpful
Outstanding interpersonal skills and collaborative work style
Need for professional licensure to be in good standing if applicable

Preferred

Prior experience in MSL role highly preferred and/or the introduction of new clinical laboratory tests preferred

Benefits

Competitive base salary and incentive compensation
Health and welfare benefits, including a gym reimbursement program
401(k) savings plan match
Employee Stock Purchase Plan
Pre-tax commuter benefits
Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.

Company

CareDx, Inc.

twittertwittertwitter
company-logo
CareDx, Inc., headquartered in South San Francisco, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.

Funding

Current Stage
Public Company
Total Funding
$574.89M
Key Investors
Bristol-Myers SquibbSprout Group
2021-01-21Post Ipo Equity· $164M
2020-06-09Post Ipo Equity· $117.1M
2018-11-13Post Ipo Equity· $52.8M

Leadership Team

leader-logo
John Hanna
President and CEO
linkedin
leader-logo
Nathan Smith
Chief Financial Officer
linkedin
Company data provided by crunchbase